Seminars in Hematology
Volume 41, Issue 2 , Pages 118-141 , April 2004

Hereditary spherocytosis—defects in proteins that connect the membrane skeleton to the lipid bilayer

  • Stefan Eber

      Affiliations

    • Division of Hematology/Oncology, Children’s Hospital Boston, Boston, MA, USA
    • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationAddress correspondence to Professor Dr Stefan Eber, Childrens Hospital of the Technical University, Koelner Place 1, D80804 Munich, Germany
    • ,
  • Samuel E Lux

      Affiliations

    • Division of Hematology/Oncology, Children’s Hospital Boston, Boston, MA, USA
    • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

References 

  1. Vanlair CF, Masius JB. De la microcythémie. Bull R Acad Med Belg. 1871;5:515–613
  2. Miraglia del Giudice E, Lombardi C, Francese M, et al.  Frequent de novo monoallelic expression of β-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency. Br J Haematol. 1998;101:251–254
  3. Özcan R, Kugler W, Feuring-Buske M, et al.  Parental mosaicism for ankyrin-1 mutations in two families with hereditary spherocytosis. Blood. 1997;90:4a; (suppl, abstr)
  4. Basseres DS, Duarte AS, Hassoun H, et al.  β-Spectrin S(ta) Barbara (A novel frameshift mutation in hereditary spherocytosis associated with detectable levels of mRNA and a germ cell line mosaicism). Br J Haematol. 2001;115:347–353
  5. Eber SW, Armbrust R, Schroter W. Variable clinical severity of hereditary spherocytosis (Relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis). J Pediatr. 1990;117:409–416
  6. Miraglia del Giudice E, Nobili B, Francese M, et al.  Clinical and molecular evaluation of non-dominant hereditary spherocytosis. Br J Haematol. 2001;112:42–47
  7. Agre P, Orringer EP, Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med. 1982;306:1155–1161
  8. Wichterle H, Hanspal M, Palek J, et al.  Combination of two mutant α-spectrin alleles underlies a severe spherocytic hemolytic anemia. J Clin Invest. 1996;98:2300–2307
  9. Ribeiro ML, Alloisio N, Almeida H, et al.  Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood. 2000;96:1602–1604
  10. Perrotta S, Nigro V, Iolascon A, et al.  Dominant hereditary spherocytosis due to band 3 Neapolis produces a life-threatening anemia at the homozygous state. Blood. 1998;92:9; (abstr)
  11. Chilcote RR, Le Beau MM, Dampier C, et al.  Association of red cell spherocytosis with deletion of the short arm of chromosome 8. Blood. 1987;69:156–159
  12. Lux S, Tse W, Menninger J, et al.  Hereditary spherocytosis associated with deletion of the human erythrocyte ankyrin gene on chromosome 8. Nature. 1990;345:736–739
  13. Fukushima Y, Byers MG, Watkins PC, et al.  Assignment of the gene for β spectrin (SPTB) to chromosome 14q23-q24.2 by situhybridization. Cytogenet Cell Genet. 1990;53:232–233
  14. Palek J, Lambert S. Genetics of the red cell membrane skeleton. Semin Hematol. 1990;27:290–332
  15. Friedman EW, Williams JC, Van Hook L. Hereditary spherocytosis in the elderly. Am J Med. 1988;84:513–516
  16. Krueger HC, Burgert EOJ. Hereditary spherocytosis in 100 children. Mayo Clin Proc. 1966;41:554–567
  17. Jensson O, Jonasson JL, Magnusson S. Studies on hereditary spherocytosis in Iceland. Acta Med Scand. 1977;201:187–195
  18. Koepke JF, Koepke JA. Reticulocytes. Clin Lab Haematol. 1986;8:169–179
  19. Guarnone R, Centenara E, Zappa M, et al.  Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis. Br J Haematol. 1996;92:150–154
  20. Pajor A, Lehoczky D, Szakacs Z. Pregnancy and hereditary spherocytosis. Report of 8 patients and a review. Arch Gynecol Obstet. 1993;253:37–42
  21. Agre P, Casella JF, Zinkham WH, et al.  Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. Nature. 1985;314:308–383
  22. Coetzer TL, Lawler J, Liu SC, et al.  Partial ankyrin and spectrin deficiency in severe, atypical hereditary spherocytosis. N Engl J Med. 1988;318:230–234
  23. Agre P, Asimos A, Casella JF, et al.  Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med. 1986;315:1579–1583
  24. Godal HC, Heist H. High prevalence of increased osmotic fragility of red blood cells among Norwegian donors. Scand J Haematol. 1981;27:30–34
  25. Eber SW, Pekrun A, Neufeldt A, et al.  Prevalence of increased osmotic fragility of erythrocytes in German blood donors (Screening using a modified glycerol lysis test). Ann Hematol. 1992;64:88–92
  26. Maberry MC, Mason RA, Cunningham FG, et al.  Pregnancy complicated by hereditary spherocytosis. Obstet Gynecol. 1992;79:735–738
  27. Iolascon A, Faienza MF, Moretti A, et al.  UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis. Blood. 1998;91:1093; (letter)
  28. Delhommeau F, Cynober T, Schischmanoff PO, et al.  Natural history of hereditary spherocytosis during the first year of life. Blood. 2000;95:393–397
  29. Tchernia G, Delhommeau F, Perrotta S, et al.  Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. BJH. 2000;1:146–152
  30. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988;25:159–172
  31. Pekrun A, Eiffert H, Eber SW, et al.  Aplastische Krisen bei hereditärer Sphärozytose. Monatsschr Kinderheilkd. 1988;136:173–175
  32. Peter G. In: Parvovirus B19, in Red Book (Report of the Committee on Infectious Diseases). (ed 24). Elk Grove Village, IL: American Academy of Pediatrics; 1997;p. 383
  33. Malinow M, Duell PB, Hess DL, et al.  Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 1998;338:1009–1015
  34. Bosma PJ, Chowdhury JR, Bakker C, et al.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med. 1995;333:1171–1175
  35. Miraglia del Giudice E, Perrotta S, Nobili B, et al.  Co-inheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood. 1998;92:470a; (suppl, abstr)
  36. Marchetti M, Quaglini S, Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis (Analyzing the decision in different clinical scenarios). J Intern Med. 1998;244:217–226
  37. Michaels LA, Cohen AR, Zhao H, et al.  Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr. 1997;130:957–960
  38. Mohandas N, Kim YR, Tycko DH, et al.  Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood. 1986;68:506–513
  39. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis (relevance to diagnosis and understanding of the variable expression of clinical severity). J Lab Clin Med. 1996;128:259–269
  40. Chasis JA, Agre P, Mohandas N. Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest. 1988;82:617–623
  41. Clark MR, Mohandas N, Shohet SB. Osmotic gradient ektacytometry (Comprehensive characterization of red cell volume and surface maintenance). Blood. 1983;61:899–910
  42. Schröter W, Kahsnitz E. Diagnosis of hereditary spherocytosis in newborn infants. J Pediatr. 1983;103:460–463
  43. Zanella A, Izzo C, Rebulla P, et al.  Acidified glycerol lysis test (A screening test for spherocytosis). Br J Haematol. 1980;45:481–486
  44. Savvides P, Shalev O, John KM, et al.  Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood. 1993;82:2953–2960
  45. Pekrun A, Eber SW, Kuhlmey A, et al.  In: Combined amkyrin and spectrin deficiency in hereditary spherocytosis. 67:1993;p. 89–93
  46. Byers PH. Killing the messenger (New insights into nonsense-mediated mRNA decay). J Clin Invest. 2002;109:3–6
  47. Jarolim P, Rubin HL, Brabec V, et al.  Comparison of the ankyrin (AC)n microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis. Blood. 1995;85:3278–3282
  48. Özcan R, Jarolim P, Lux SE, et al.  Simultaneous (AC)n microsatellite polymorphism analysis and SSCP screening is an efficient strategy for detecting ankyrin-1 mutations in dominant hereditary spherocytosis. Br J Haematol. 2003;122:669–677
  49. Miraglia del Giudice E, Francese M, Nobili B, et al.  High frequency of de novo mutations in ankyrin gene (ANK1) in children with hereditary spherocytosis. J Pediatr. 1998;132:117–120
  50. Eber SW, Gonzalez JM, Lux ML, et al.  Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nature Genet. 1996;13:214–218
  51. Eber SW, Langendorfer CM, Ditzig M, et al.  Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis (Impact of insufficient antibody response to pneumococcal infection). Ann Hematol. 1999;78:524–528
  52. Green JB, Shackford SR, Sise MJ, et al.  Late septic complications in adults following splenectomy for trauma (A prospective analysis in 144 patients). J Trauma. 1986;26:999–1004
  53. Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis (Postsplenectomy sepsis revisited). Pediatr Dev Pathol. 2001;4:105–121
  54. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate (Actual versus perceived risks). Br J Surg. 1991;78:1031–1038
  55. Schwartz PE, Sterioff S, Mucha P, et al.  Postsplenectomy sepsis and mortality in adults. JAMA. 1982;248:2279–2283
  56. Schilling RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med. 1995;122:187–188
  57. Schilling RF. Spherocytosis, splenectomy, strokes, and heat attacks. Lancet. 1997;350:1677–1678
  58. Robinette CD, Fraumeni JFJ. Splenectomy and subsequent mortality in veterans of the 1939–45 war. Lancet. 1977;2:127
  59. Bader-Meunier B, Gauthier F, Archambaud F, et al.  Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood. 2001;97:399–403
  60. de Buys Roessingh AS, de Lagausie P, Rohrlich P, et al.  Follow-up of partial splenectomy in children with hereditary spherocytosis. J Pediatr Surg. 2002;37:1459–1463
  61. Eber SW, Bolkenius M, Heidemann P, et al.  Subtotale Splenektomie bei hereditärer Sphärozytose im Kindesalter. Chir Gastroenterol. 2001;17(suppl):12–17
  62. Rice HE, Oldham KT, Hillery CA, et al.  Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann Surg. 2003;237:281–288
  63. Tchernia G, Gauthier F, Mielot F, et al.  Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis. Blood. 1993;81:2014–2020
  64. Katkhouda N, Hurwitz MB, Rivera RT, et al.  Laparoscopic splenectomy (Outcome and efficacy in 103 consecutive patients). Ann Surg. 1998;228:568–578
  65. Eber SW, Belohradsky BH, Weiss M. Infektionsprophylaxe bei Asplenie. Klin Pädiatrie 213 Sonderheft. 2001;1:1–4
  66. Walensky LD, Narla M, Lux SE. Disorders of the red blood cell membrane. In:  Handin RI,  Lux SE,  Stossel TP editor. Blood (Principles and Practice of Hematology). (ed 2). Philadelphia, PA: Lippincott Williams & Wilkins; 2003;p. 1709–1858
  67. Yawata Y. Hereditary spherocythosis. In: Cell Membrane. Weinheim, Germany: Wiley-VCH; 2003;p. 173–212
  68. Lanciotti M, Perutelli P, Valetto A, et al.  Ankyrin deficiency is the most common defect in dominant and non dominant hereditary spherocytosis. Haematologica. 1997;82:460–462
  69. Saad ST, Costa FF, Vicentim DL, et al.  Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol. 1994;88:295–299
  70. Yawata Y, Kanzaki A, Yawata A, et al.  Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population. Int J Hematol. 2000;71:118–135
  71. Miraglia del Giudice EM, Hayette S, Bozon M, et al.  Ankyrin Napoli (A de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis). Br J Haematol. 1996;93:828–834
  72. Randon J, Miraglia del Giudice E, Bozon M, et al.  Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis: Three new ANK1 variants: Ankyrins Bari, Napoli II and Anzio. Br J Haematol. 1997;96:500–506
  73. Woods CM, Lazarides E. Spectrin assembly in avian erythroid development is determined by competing reactions of subunit homo- and hetero-oligomerization. Nature. 1986;321:85–89
  74. Jarolim P, Rubin HL, Brabec V, et al.  A nonsense mutation 1669Glu→Ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis. J Clin Invest. 1995;95:941–947
  75. Gallagher PG, Nilson DG, Wong C, et al.  A two base pair deletion at position -72/-73 of the ankyrin-1 promoter associated with hereditary spherocytosis disrupts TFIID complex binding and decreases transcription of a linked reporter gene. Blood. 2002;100:77; (suppl, abstr)
  76. Weisbein JL, Wong C, Cline AP, et al.  Mutations at positions −108 and −153 of the erythroid ankyrin promoter decrease expression in transgenic mice by disrupting insular function. Blood. 2002;100:78; (suppl, abstr)
  77. Eber SW, Pekrun A, Reinhardt D, et al.  Hereditary spherocytosis with ankyrin Walsrode, a variant ankyrin with decreased affinity for band 3. Blood. 1994;84:362a; (suppl, abstr)
  78. Dhermy D, Galand C, Bournier O, et al.  Heterogenous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects. Br J Haematol. 1997;98:32–40
  79. Jarolim P, Rubin HL, Brabec V, et al.  Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood. 1995;85:634–640
  80. Jarolim P, Rubin HL, Liu SC, et al.  Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3 PRAGUE). J Clin Invest. 1994;93:121–130
  81. Vince JW, Reithmeier RA. Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte C1-/HCO3- exchanger. J Biol Chem. 1998;273:28430–28437
  82. Kanzaki A, Hayette S, Morle L, et al.  Total absence of protein 4.2 and partial deficiency of band 3 in hereditary spherocytosis. Br J Haematol. 1997;99:522–530
  83. Peters LL, Shivdasani RA, Liu SC, et al.  Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 1996;86:917–927
  84. Jarolim P, Murray JL, Rubin HL, et al.  Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 1996;88:4366–4374
  85. Rysava R, Tesar V, Jirsa MJ, et al.  Incomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) gene. Nephrol Dial Transplant. 1997;12:1869–1873
  86. Lima PR, Gontijo JA, Lopes de Faria JB, et al.  Band 3 Campinas (A novel splicing mutation in the band 3 gene (AE1) associated with hereditary spherocytosis, hyperactivity of Na+/Li+ countertransport and an abnormal renal bicarbonate handling). Blood. 1997;90:2810–2818
  87. Jarolim P, Shayakul C, Prabakaran D, et al.  Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger. J Biol Chem. 1998;273:6380
  88. Bruce LJ, Cope DL, Jones GK, et al.  Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997;100:1693–1707
  89. Inaba M, Yawata A, Koshino I, et al.  Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest. 1996;97:1804–1817
  90. Karet FE, Gainza FJ, Gyory AZ, et al.  Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci USA. 1998;95:6337–6342
  91. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol. 1993;30:249–283
  92. Rybicki AC, Heath R, Wolf JL, et al.  Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia. Evidence for a role of protein 4.2 in stabilizing ankyrin on the membrane. J Clin Invest. 1988;81:893–901
  93. Lombardo CR, Willardson BM, Low PS. Localization of the protein 4.1-binding site on the cytoplasmic domain of erythrocyte membrane band 3. J Biol Chem. 1992;267:9540–9546
  94. Waugh RE, Agre P. Reductions of erythrocyte membrane viscoelastic coefficients reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest. 1988;81:133–141
  95. Hanspal M, Yoon SH, Yu H, et al.  Molecular basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis (Evidence implicating a primary defect of ankyrin). Blood. 1991;77:165–173
  96. Tse WT, Gallagher PG, Jenkins PB, et al.  Amino-acid substitution in α-spectrin commonly coinherited with nondominant hereditary spherocytosis. Am J Hematol. 1997;54:233–241
  97. Jarolim P, Wichterle H, Palek J, et al.  The low expression α-spectrin LEPRA is frequently associated with autosomal recessive/nondominant hereditary spherocytosis. Blood. 1996;88:4a; (suppl, abstr)
  98. Hassoun H, Vassiliadis JN, Murray J, et al.  Molecular basis of spectrin deficiency in β-spectrin Durham. A deletion within β-spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis. J Clin Invest. 1995;96:2623–2629
  99. Becker PS, Tse WT, Lux SE, et al.  β-Spectrin Kissimmee (A spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1). J Clin Invest. 1993;92:612–616
  100. Wolfe LC, John KM, Falcone JC, et al.  A genetic defect in the binding of protein 4.1 to spectrin in a kindred with hereditary spherocytosis. N Engl J Med. 1982;307:1367–1374
  101. Hassoun H, Vassiliadis JN, Murray J, et al.  Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood. 1997;90:398–406
  102. Cooper RA, Jandl JH. The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest. 1969;48:736–744
  103. Liu SC, Derick LH, Duquette MA, et al.  Separation of the lipid bilayer from the membrane skeleton during discocyte-echinocyte transformation of human erythrocyte ghosts. Eur J Cell Biol. 1989;49:358–365
  104. Zachee P, Boogaerts MA, Hellamans L, et al.  Adverse role of the spleen in hereditary spherocytosis (Evidence by the use of the atomic force microscope). Br J Haematol. 1992;80:264–265
  105. Da Costa L, Mohandas N, Sorette M, et al.  Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood. 2001;98:2894–2899
  106. Corbett JD, Agre P, Palek J, et al.  Differential control of band 3 lateral and rotational mobility in intact red cells. J Clin Invest. 1994;94:683–688
  107. Cho MR, Eber SW, Liu SC, et al.  Regulation of band 3 rotational mobility by ankyrin in intact human red cells. Biochemistry. 1998;37:17828–17835
  108. Reinhardt D, Witt O, Miosge N, et al.  Increase in band 3 density and aggregation in hereditary spherocytosis. Blood Cells Mol Dis. 2001;27:399–406
  109. Weiss L. A scanning electron microscopic study of the spleen. Blood. 1974;43:665–691
  110. Groom AC. Microcirculation of the spleen (New concepts, new challenges). Microvasc Res. 1987;34:269–289
  111. Fujino T, Ishikawa T, Inoue M, et al.  Characterization of membrane-bound serine protease related to degradation of oxidatively damaged erythrocyte membrane proteins. Biochim Biophys Acta. 1998;1374:47–55
  112. Coleman DH, Finch CA. Effect of adrenal steroids in hereditary spherocytic anemia. J Lab Clin Med. 1956;47:602–610
  113. Reliene R, Mariani M, Zanella A, et al.  Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood. 2002;100:2208–2215
  114. Peters LL, Barker JE. Spontaneous and targeted mutations in erythrocyte membrane skeleton genes (Mouse models of hereditary spherocytosis). In:  Zon LI editors. Hematopoiesis, a Developmental Approach. Oxford, UK: Oxford University Press; 2001;p. 582–609
  115. Wandersee N, Birkenmeier C, Bodine D, et al.  Mutations in the murine erythroid α-spectrin gene alter spectrin mRNA and protein levels and spectrin incorporation into the red blood cell membrane skeleton. Blood. 2003;101:325–330
  116. Kaysser TM, Wandersee NJ, Bronson RT, et al.  Thrombosis and secondary hemochromatosis play major roles in the pathogenesis of jaundiced and spherocytic mice, murine models for hereditary spherocytosis. Blood. 1997;90:4610–4619
  117. Wandersee NJ, Lee JC, Kaysser TM, et al.  Hematopoietic cells from α-spectrin-deficient mice are sufficient to induce thrombotic events in hematopoietically ablated recipients. Blood. 1998;92:4856–4863
  118. Bodine DM, Birkenmeier CS, Barker JE. Spectrin deficient inherited hemolytic anemias in the mouse (Characterization by spectrin synthesis and mRNA activity in reticulocytes). Cell. 1984;40:959–969
  119. Peters LL, Turtzo LC, Birkenmeier CS, et al.  Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice. Blood. 1993;81:2144–2149
  120. Peters LL, Birkenmeier CS, Bronson RT, et al.  Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol. 1991;114:1233–1241
  121. Hassoun H, Wang Y, Vassiliadis J, et al.  Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo. Blood. 1998;92:1785
  122. Peters LL, Andersen SG, Gwynn B, et al.  A QTL on mouse chromosome 12 modifies the band 3 null phenotype (β spectrin is a candidate gene). Blood. 2001;98:437a; (suppl, abstr)
  123. Paw BH, Zhou Y, Li R, et al.  Cloning of the zebrafish retsina blood mutation (Mutations in erythroid band 3 in dyserythropoiesis and cytokinesis defects). Blood. 2000;96:440a; (suppl, abstr)
  124. Liao EC, Paw BH, Peters LL, et al.  Hereditary spherocytosis in zebrafish riesling illustrates evolution of erythroid β-spectrin structure, and function in red cell morphogenesis and membrane stability. Development. 2000;127:5123–5132
  125. Shafizadeh E, Paw B, Foott H, et al.  Characterization of zebrafish merlot/chablis as non-mammalian vertebrate models for severe congenital anemia due to protein 4.1 deficiency. Development. 2002;129:4359–4370

☆ S.E. is supported by the Deutsche Forschungsgemeinschaft (DFG 99/6–1+2). S.E.L. is supported by Grants No. R01 DK34083 and P01 HL32262 from the National Institutes of Health.

PII: S0037-1963(04)00003-4

doi: 10.1053/j.seminhematol.2004.01.002

Seminars in Hematology
Volume 41, Issue 2 , Pages 118-141 , April 2004

Article Tools

* Image Usage & Resolution